For many biotech and pharma companies, expanding their businesses into China is a financially enticing yet perplexing proposition due to language barriers, cultural differences, legal issues, and a lack of resources on the ground. Businesses we work with take advantage of our cross-cultural expertise, access to local companies, investors, KOLs and government agencies, and ability to bridge the gap between the East and the West.

We provide advisory expertise in the areas of cross-border licensing, fundraising, and M&A. BioSense’s goal is to help meet the needs of Chinese companies with new projects and technologies and U.S. and European companies with fundraising, partnering and entry into the Chinese market.

Learn more about the BioSense team